FFT analysis of isoflurane levels, suppression duration comparison across conditions, and sample oscillations at different isoflurane levels. by Mohammad-Mahdi Abolghasemi (22367296)

Minimal data set. by Zhaoping Meng (4875040)

“…Twenty-two differential metabolites (VIP ≥ 1) were identified using untargeted metabolomics. 3 primary metabolites, namely mannose, pyruvate, and shikimic acid, together with 2 secondary metabolites, phenylalanine and mevalonic acid, were observed to decrease. 17 secondary metabolites, including Schisandrin A, Schisandrin B, Schisandrin C, Gomisin D, Gomisin G, Gomisin H, Benzoylgomisin H, Benzoylgomisin O,Angeloylgomisin P, Catechin, Isorhamnetin, Luteolin, Cinnamic acid, Hydroxycinnamic acid, Hexahydrocurcumin, Coniferyl alcohol, Phenylalanine, Terpinolene and Mevalonic acid, exhibited increases in their levels by 10.64, 1.84, 1.40, 1.64, 4.46, 8.18, 1.72, 10.20, 2.08, 1.27, 1.57, 1.18, 2.01, 1.12, 1.88, 1.15, and 3.17-fold, respectively. …”

Canonical Pathways. by Muhammad N. Aslam (6598001)

“…</p><p>Results</p><p>Subjects who received Aquamin for the complete 180-day period (a total of 12) demonstrated improvements in all biomarkers (CRP, fCAL, ALP, ALPI, and Geboes scoring); this was not observed in the placebo group (16 subjects). When cumulative pre-post differences were compared between the Aquamin and placebo groups, Aquamin treatment significantly decreased these differences (a 24% decrease as compared to a 38% increase with placebo, p = 0.0284). …”

Fragmentation patterns for Schisandrin A. by Zhaoping Meng (4875040)

“…Twenty-two differential metabolites (VIP ≥ 1) were identified using untargeted metabolomics. 3 primary metabolites, namely mannose, pyruvate, and shikimic acid, together with 2 secondary metabolites, phenylalanine and mevalonic acid, were observed to decrease. 17 secondary metabolites, including Schisandrin A, Schisandrin B, Schisandrin C, Gomisin D, Gomisin G, Gomisin H, Benzoylgomisin H, Benzoylgomisin O,Angeloylgomisin P, Catechin, Isorhamnetin, Luteolin, Cinnamic acid, Hydroxycinnamic acid, Hexahydrocurcumin, Coniferyl alcohol, Phenylalanine, Terpinolene and Mevalonic acid, exhibited increases in their levels by 10.64, 1.84, 1.40, 1.64, 4.46, 8.18, 1.72, 10.20, 2.08, 1.27, 1.57, 1.18, 2.01, 1.12, 1.88, 1.15, and 3.17-fold, respectively. …”

Chemical structure of a lignan. by Zhaoping Meng (4875040)

“…Twenty-two differential metabolites (VIP ≥ 1) were identified using untargeted metabolomics. 3 primary metabolites, namely mannose, pyruvate, and shikimic acid, together with 2 secondary metabolites, phenylalanine and mevalonic acid, were observed to decrease. 17 secondary metabolites, including Schisandrin A, Schisandrin B, Schisandrin C, Gomisin D, Gomisin G, Gomisin H, Benzoylgomisin H, Benzoylgomisin O,Angeloylgomisin P, Catechin, Isorhamnetin, Luteolin, Cinnamic acid, Hydroxycinnamic acid, Hexahydrocurcumin, Coniferyl alcohol, Phenylalanine, Terpinolene and Mevalonic acid, exhibited increases in their levels by 10.64, 1.84, 1.40, 1.64, 4.46, 8.18, 1.72, 10.20, 2.08, 1.27, 1.57, 1.18, 2.01, 1.12, 1.88, 1.15, and 3.17-fold, respectively. …”

Bioclimatic variables used for MaxEnt modeling. by Dong-Joo Kim (1797640)

“…Under the SSP2-4.5 scenario, potential suitable area for <i>S. koreana</i> increased, while those for <i>B. ermanii</i>, <i>T. cuspidata</i> decreased by the 2090s. Under the SSP5-8.5 scenario, suitable areas for <i>S. koreana</i>, <i>B. ermanii</i>, <i>T. cuspidata</i> decreased by 33.6%, 98.9%, and 90.1%, respectively. …”

Opioid consumption data. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”

Prescription data. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”

Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”

Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”

Localization and expression of cell-to-cell connection proteins in bma-miRNA transfected and NC hLECs. by Hailey Johnson (18217167)

“…(<b>I</b><b>–</b><b>K)</b> ITGB1 (red) expression appears similar across treatment groups (I – NC, J – bma-miR-5864, and K – bma-mir-86), with mildly decreased expression observed in parasite miRNA-treated cells (J, K). …”

Raw data_clean. by Carlos Sepúlveda (15272797)

“…</p><p>Results</p><p>Significant differences were observed in maximal oxygen consumption values between boys and girls across different weight categories: healthy weight (♀ 35.0 ± 5.9 ml·kg^-1·min^-1; ♂ 38.8 ± 6.1 ml·kg^-1·min^-1), overweight (♀ 32.7 ± 5.2 ml·kg^-1·min^-1; ♂ 35.9 ± 5.3 ml·kg^-1·min^-1), and obesity (♀ 27.6 ± 6.3 ml·kg^-1·min^-1; ♂ 32.8 ± 5.8 ml·kg^-1·min^-1) (p < 0.05). …”

Experimental design. by Carlos Sepúlveda (15272797)

“…</p><p>Results</p><p>Significant differences were observed in maximal oxygen consumption values between boys and girls across different weight categories: healthy weight (♀ 35.0 ± 5.9 ml·kg^-1·min^-1; ♂ 38.8 ± 6.1 ml·kg^-1·min^-1), overweight (♀ 32.7 ± 5.2 ml·kg^-1·min^-1; ♂ 35.9 ± 5.3 ml·kg^-1·min^-1), and obesity (♀ 27.6 ± 6.3 ml·kg^-1·min^-1; ♂ 32.8 ± 5.8 ml·kg^-1·min^-1) (p < 0.05). …”

Characterization of the participants. by Carlos Sepúlveda (15272797)

“…</p><p>Results</p><p>Significant differences were observed in maximal oxygen consumption values between boys and girls across different weight categories: healthy weight (♀ 35.0 ± 5.9 ml·kg^-1·min^-1; ♂ 38.8 ± 6.1 ml·kg^-1·min^-1), overweight (♀ 32.7 ± 5.2 ml·kg^-1·min^-1; ♂ 35.9 ± 5.3 ml·kg^-1·min^-1), and obesity (♀ 27.6 ± 6.3 ml·kg^-1·min^-1; ♂ 32.8 ± 5.8 ml·kg^-1·min^-1) (p < 0.05). …”

Trial design. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Schedule of the trial. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Clinical symptoms scoring system. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Effects of βHB treatment on edema and NDS 3 days after ICH. by Noam H. Sander (13977976)

“…E) Both groups had similar NDS scores at baseline. Significant neurological deficits were observed in both treatment groups 3 days after ICH (p<0.0001). …”

Experimental procedures. by Ellen Chan (22177558)

“…Real-time increasing trend during backward walking and real time decreasing trend of ipsilateral MF to ES ratio during forward walking were observed in stance phase of both legs, with time-and-group interaction effect at 6^th (p = 0.007) and 12^th minute (p = 0.006) during walking training in left stance phase.…”